AIG
VTGN icon

American International Group’s VistaGen Therapeutics VTGN Stock Holding History

American International Group’s Portfolio VTGN Stock Details VTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,329
Closed -$12.5K – 3175
2023
Q1 		$12.5K Buy
3,329
+66
+2% +$346 ﹤0.01% 2936
2022
Q4 		$10.1K Buy
3,263
+181
+6% +$681 ﹤0.01% 2988
2022
Q3 		$14K Buy
3,082
+44
+1% +$436 ﹤0.01% 3008
2022
Q2 		$80K Sell
3,038
-173
-5% -$6.11K ﹤0.01% 2710
2022
Q1 		$119K Sell
3,211
-226
-7% -$9.85K ﹤0.01% 2524
2021
Q4 		$201K Sell
3,437
-103
-3% -$6.7K ﹤0.01% 2370
2021
Q3 		$291K Sell
3,540
-33
-0.9% -$2.87K ﹤0.01% 2202
2021
Q2 		$338 Buy
+3,573
New +$265K ﹤0.01% 2178

Other funds holding VTGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American International Group's VTGN Position: Q2 2023 in Review

American International Group sold out of VistaGen Therapeutics (VTGN) in Q2 2023, closing a stake of 3,329 shares — an estimated $12.5K sold.

American International Group first reported a position in VTGN in Q2 2021 and held it in 8 quarters. The position peaked at $291K in Q3 2021. 33 funds tracked by Wall St. Rank hold VTGN as of Q2 2023.

  • American International Group reported no remaining VistaGen Therapeutics position as of Q2 2023 after selling out during the quarter.
  • American International Group sold 3,329 VistaGen Therapeutics shares in Q2 2023, an estimated $12.5K.
  • American International Group first reported a position in VistaGen Therapeutics in Q2 2021 and held it in 8 quarters.
  • American International Group's VistaGen Therapeutics position peaked at $291K in Q3 2021.
  • 33 funds tracked by Wall St. Rank held VistaGen Therapeutics as of Q2 2023.

Based on American International Group's 13F filing for Q2 2023, filed 4 Aug 2023.